
Keywords: کاورلین 1; BBB; blood-brain barrier; BSA; bovine serum albumin; Cav-1; caveolin 1; Cav-2; caveolin 2; Cav-3; caveolin 3; CCI; controlled cortical impact; CSD; caveolin scaffolding domain; d; days post injury; eNOS; endothelial nitric oxide synthase; GFAP; glial fi